A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), ...

Discover an informative webinar featuring leading researchers as they discuss advancements in biomarker discovery for Alzheimer's disease (AD) and related dementias. This webinar will showcase how the ...

For decades, diagnosing Parkinson’s disease has been a challenge, often requiring clinical evaluations, DaT SPECT scans, and ...

“As presented at the recent International Lewy Body Dementia Conference ... study for evidence of Alzheimer’s disease related co-pathology, were more pronounced. On CGIC, which was ...

In January 2025, the Company presented at the 8th International Lewy Body Dementia Conference ... Patients with Alzheimer’s disease (AD) co-pathology, as assessed by plasma ptau181 levels ...

FTD patients with AD co-pathology performed worse on memory tests ... 125 with AD, 10 with dementia with Lewy bodies, and 16 age-matched controls. The FTD group comprised 76 people with behavioral ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

Dr. Solomon Carter Fuller was the first Black psychiatrist and neurologist in the United States but has long been overlooked.